83 FR 2167 - Advisory Council on Alzheimer's Research, Care, and Services; Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 83, Issue 10 (January 16, 2018)
Federal Register Volume 83, Issue 10 (January 16, 2018)
| Page Range | 2167-2167 | |
| FR Document | 2018-00480 |
[Federal Register Volume 83, Number 10 (Tuesday, January 16, 2018)] [Notices] [Page 2167] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-00480] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council on Alzheimer's Research, Care, and Services; Meeting AGENCY: Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer's Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. During the January meeting, the Research Subcommittee will be taking charge of the theme, focusing on the process from targets to treatments. The Council will hear speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting will also include discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. DATES: The meeting will be held on January 26, 2018 from 9:00 a.m. to 5:00 p.m. EDT. ADDRESSES: The meeting will be held in Room 800 in the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Comments: Time is allocated in the afternoon on the agenda to hear public comments. The time for oral comments will be limited to two (2) minutes per individual. In lieu of oral comments, formal written comments may be submitted for the record to Rohini Khillan, OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to [email protected]. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932, [email protected]. Note: Seating may be limited. Those wishing to attend the meeting must send an email to [email protected] and put ``January 26 Meeting Attendance'' in the Subject line by Tuesday, January 16, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: During the January meeting, the Research Subcommittee will be taking charge of the theme, focusing on the process from targets to treatments. The Council will hear speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting will also include discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. Procedure and Agenda: This meeting is open to the public. Please allow 30 minutes to go through security and walk to the meeting room. The meeting will also be webcast at www.hhs.gov/live. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer's Project Act. The panel is governed by provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: January 9, 2018. John R. Graham, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2018-00480 Filed 1-12-18; 8:45 am] BILLING CODE 4150-05-P
![Federal Register / Vol. 83, No. 10 / Tuesday, January 16, 2018 / Notices 2167
If you need special accommodations accessible at https:// FOR FURTHER INFORMATION CONTACT:
due to a disability, please contact Susan www.regulations.gov. It may be viewed Rohini Khillan (202) 690–5932,
Monahan, Center for Devices and at the Dockets Management Staff (see rohini.khillan@hhs.gov. Note: Seating
Radiological Health, Food and Drug ADDRESSES). A link to the transcript will
may be limited. Those wishing to attend
Administration, 10903 New Hampshire also be available on the internet at the meeting must send an email to
Ave., Bldg. 32, Rm. 5231, Silver Spring, https://www.fda.gov/MedicalDevices/
napa@hhs.gov and put ‘‘January 26
MD 20993–0002, 301–796–5661, or NewsEvents/WorkshopsConferences/
email: Susan.Monahan@fda.hhs.gov, no Meeting Attendance’’ in the Subject line
default.htm.
later than May 8, 2018. by Tuesday, January 16, so that their
Dated: January 9, 2018. names may be put on a list of expected
Requests for Oral Presentations:
Leslie Kux, attendees and forwarded to the security
During online registration you may
indicate if you wish to present during a Associate Commissioner for Policy. officers at the Department of Health and
public comment session or participate [FR Doc. 2018–00551 Filed 1–12–18; 8:45 am] Human Services. Any interested
in a specific session, and which topic(s) BILLING CODE 4164–01–P member of the public who is a non-U.S.
you wish to address. We will do our citizen should include this information
best to accommodate requests to make at the time of registration to ensure that
public comments. Individuals and DEPARTMENT OF HEALTH AND the appropriate security procedure to
organizations with common interests are HUMAN SERVICES gain entry to the building is carried out.
urged to consolidate or coordinate their Although the meeting is open to the
presentations, and request time for a Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting public, procedures governing security
joint presentation, or submit requests for and the entrance to Federal buildings
designated representatives to participate AGENCY: Assistant Secretary for may change without notice. If you wish
in the focused sessions. Following the Planning and Evaluation, HHS. to make a public comment, you must
close of registration, we will determine ACTION: Notice of meeting. note that within your email.
the amount of time allotted to each
presenter and the approximate time SUMMARY: This notice announces the SUPPLEMENTARY INFORMATION: Notice of
each oral presentation is to begin, and public meeting of the Advisory Council these meetings is given under the
will select and notify participants by on Alzheimer’s Research, Care, and Federal Advisory Committee Act (5
May 16, 2018, midnight Eastern Time. Services (Advisory Council). The U.S.C. App. 2, section 10(a)(1) and
All requests to make oral presentations Advisory Council on Alzheimer’s (a)(2)). Topics of the Meeting: During
must be received by the close of Research, Care, and Services provides the January meeting, the Research
registration on May 14, 2018, 4 p.m. advice on how to prevent or reduce the Subcommittee will be taking charge of
Eastern Time. If selected for burden of Alzheimer’s disease and the theme, focusing on the process from
presentation, any presentation materials related dementias on people with the targets to treatments. The Council will
must be emailed to Scott Colburn (see disease and their caregivers. During the hear speakers on the preclinical
FOR FURTHER INFORMATION CONTACT) no January meeting, the Research pipeline, the clinical trial pipeline, and
later than May 18, 2018, midnight Subcommittee will be taking charge of
Eastern Time. No commercial or the industry perspective. The meeting
the theme, focusing on the process from will also include discussion of a driver
promotional material will be permitted targets to treatments. The Council will
to be presented or distributed at the diagram to guide the Council’s future
hear speakers on the preclinical work, updates and a report from the
public workshop. pipeline, the clinical trial pipeline, and
Streaming Webcast of the Public October Care Summit, and federal
the industry perspective. The meeting
Workshop: This public workshop will workgroup updates.
will also include discussion of a driver
also be webcast. The webcast link will diagram to guide the Council’s future Procedure and Agenda: This meeting
be available on the registration web page work, updates and a report from the is open to the public. Please allow 30
after May 14, 2018. Please visit FDA’s October Care Summit, and federal minutes to go through security and walk
Medical Devices News & Events— workgroup updates. to the meeting room. The meeting will
Workshops & Conferences calendar also be webcast at www.hhs.gov/live.
(https://www.fda.gov/MedicalDevices/ DATES: The meeting will be held on
NewsEvents/WorkshopsConferences/ January 26, 2018 from 9:00 a.m. to 5:00 Authority: 42 U.S.C. 11225; Section 2(e)(3)
default.htm) and select this event from p.m. EDT. of the National Alzheimer’s Project Act. The
the list of items provided. Organizations ADDRESSES: The meeting will be held in panel is governed by provisions of Public
are requested to register all participants, Room 800 in the Hubert H. Humphrey Law 92–463, as amended (5 U.S.C. Appendix
but to view using one connection per Building, 200 Independence Avenue 2), which sets forth standards for the
location. SW, Washington, DC 20201. formation and use of advisory committees.
If you have never attended a Connect Comments: Time is allocated in the Dated: January 9, 2018.
Pro event before, test your connection at afternoon on the agenda to hear public John R. Graham,
https://collaboration.fda.gov/common/ comments. The time for oral comments
will be limited to two (2) minutes per Acting Assistant Secretary for Planning and
help/en/support/meeting_test.htm. To
Evaluation.
get a quick overview of the Connect Pro individual. In lieu of oral comments,
formal written comments may be [FR Doc. 2018–00480 Filed 1–12–18; 8:45 am]
program, visit https://www.adobe.com/
go/connectpro_overview. FDA has submitted for the record to Rohini BILLING CODE 4150–05–P
daltland on DSKBBV9HB2PROD with NOTICES
verified the website addresses in this Khillan, OASPE, 200 Independence
document, as of the date this document Avenue SW, Room 424E, Washington,
publishes in the Federal Register, but DC 20201. Comments may also be sent
websites are subject to change over time. to napa@hhs.gov. Those submitting
Transcripts: Please be advised that as written comments should identify
soon as a transcript of the public themselves and any relevant
workshop is available, it will be organizational affiliations.
VerDate Sep<11>2014 22:48 Jan 12, 2018 Jkt 244001 PO 00000 Frm 00037 Fmt 4703 Sfmt 9990 E:\FR\FM\16JAN1.SGM 16JAN1](https://thefederalregister.org/doc/83_FR_2177/page/1.svg)
Document Created: 2018-01-13 02:02:40
Document Modified: 2018-01-13 02:02:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | The meeting will be held on January 26, 2018 from 9:00 a.m. to 5:00 p.m. EDT. | |
| Contact | Rohini Khillan (202) 690-5932, [email protected] Note: Seating may be limited. Those wishing to attend the meeting must send an email to [email protected] and put ``January 26 Meeting Attendance'' in the Subject line by Tuesday, January 16, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. | |
| FR Citation | 83 FR 2167 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR